Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.18%23.37M | -19.40%15.78M | -2.72%22.94M | 49.52%89.99M | 31.98%27.06M | 12.56%19.78M | 42.90%19.58M | 180.13%23.58M | -55.36%60.19M | 145.58%20.5M |
| Cost of revenue | 10.51%25.13M | -14.40%19.46M | 10.48%26.81M | 51.35%101.06M | 42.49%31.32M | 10.34%22.74M | 58.38%22.73M | 146.89%24.27M | -29.89%66.77M | 139.38%21.98M |
| Gross profit | 40.78%-1.75M | -16.57%-3.68M | -464.82%-3.87M | -68.13%-11.07M | -187.98%-4.27M | 2.50%-2.96M | -382.57%-3.16M | 51.45%-685K | -116.63%-6.58M | -77.35%-1.48M |
| Operating expense | -0.43%1.62M | 2.02%1.62M | 2.05%1.6M | 32.17%10.38M | 75.23%3.17M | 1.56%1.63M | 45.90%1.58M | -14.54%1.56M | -17.35%7.85M | -54.49%1.81M |
| Selling and administrative expenses | -0.43%1.62M | 2.02%1.62M | 2.05%1.6M | 25.59%7.94M | 75.23%3.17M | 1.56%1.63M | 45.90%1.58M | -14.54%1.56M | -17.60%6.32M | -15.86%1.81M |
| -General and administrative expense | -0.43%1.62M | 2.02%1.62M | 2.05%1.6M | 25.59%7.94M | 75.23%3.17M | 1.56%1.63M | 45.90%1.58M | -14.54%1.56M | -17.60%6.32M | -15.86%1.81M |
| Other operating expenses | ---- | ---- | ---- | 49.52%2.62M | ---- | ---- | ---- | ---- | -20.26%1.75M | ---- |
| Total other operating income | ---- | ---- | ---- | -18.50%181.01K | ---- | ---- | ---- | ---- | -39.81%222.11K | ---- |
| Operating profit | 26.47%-3.37M | -11.71%-5.29M | -143.06%-5.46M | -48.57%-21.44M | -125.99%-7.44M | 1.10%-4.59M | -172.51%-4.74M | 30.62%-2.25M | -147.97%-14.43M | 31.60%-3.29M |
| Net non-operating interest income (expenses) | -52.94%32K | -36.67%57K | -42.50%46K | -15.01%290.3K | -42.22%52K | -17.07%68K | 18.42%90K | -13.98%80K | -19.15%341.55K | -31.54%90K |
| Non-operating interest income | -52.94%32K | -36.67%57K | -42.50%46K | -15.01%290.3K | -42.22%52K | -17.07%68K | 18.42%90K | -13.98%80K | -19.15%341.55K | -31.54%90K |
| Net investment income | -16.64%396.91K | -86.79%476.14K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | 51.6K | ||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -25.02%2M | 90.53%2.67M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | -72.17%133.41K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -86.44%-73.41K | ---- |
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 86.36%-60K | ---- |
| Other non-operating income (expenses) | 15,600.00%620K | -59.94%264K | -35.02%579K | 0.00%264.3K | -50.00%-1.32M | -100.49%-4K | -36.27%659K | -18.48%891K | -3.08%264.3K | 70.03%-880K |
| Income before tax | 39.84%-2.72M | -24.64%-4.97M | -278.94%-4.84M | -76.12%-18.49M | -113.31%-8.7M | -21.00%-4.52M | -534.34%-3.99M | 37.83%-1.28M | -128.95%-10.5M | -91.45%-4.08M |
| Income tax | 0 | 0 | 0 | 90.40%-250.73K | 0 | 0 | 94.48%-24K | 72.85%-227K | -130.39%-2.61M | 40.36%-310K |
| Net income | 39.84%-2.72M | -25.39%-4.97M | -360.86%-4.84M | -131.25%-18.24M | -130.85%-8.7M | -67.09%-4.52M | -1,944.33%-3.97M | 13.79%-1.05M | -128.51%-7.89M | -133.97%-3.77M |
| Net income continuous operations | 39.84%-2.72M | -25.39%-4.97M | -360.86%-4.84M | -131.25%-18.24M | -130.85%-8.7M | -67.09%-4.52M | -1,944.33%-3.97M | 13.79%-1.05M | -128.51%-7.89M | -133.97%-3.77M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 39.84%-2.72M | -25.39%-4.97M | -360.86%-4.84M | -131.25%-18.24M | -130.85%-8.7M | -67.09%-4.52M | -1,944.33%-3.97M | 13.79%-1.05M | -128.51%-7.89M | -133.97%-3.77M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 39.84%-2.72M | -25.39%-4.97M | -360.86%-4.84M | -131.25%-18.24M | -130.85%-8.7M | -67.09%-4.52M | -1,944.33%-3.97M | 13.79%-1.05M | -128.51%-7.89M | -133.97%-3.77M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 39.61%-0.0125 | -25.27%-0.0228 | -362.50%-0.0222 | -131.30%-0.0835 | -131.40%-0.0398 | -66.94%-0.0207 | -1,922.22%-0.0182 | 14.29%-0.0048 | -126.70%-0.0361 | -152.94%-0.0172 |
| Diluted earnings per share | 39.61%-0.0125 | -25.27%-0.0228 | -362.50%-0.0222 | -131.30%-0.0835 | -131.40%-0.0398 | -66.94%-0.0207 | -1,922.22%-0.0182 | 14.29%-0.0048 | -127.08%-0.0361 | -132.43%-0.0172 |
| Dividend per share | 0 | 0 | 0 | -50.00%0.02 | 0.00%0.02 | 0 | 0 | 0 | -6.33%0.04 | 0.02 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.